Olr400 inhibitors are a class of chemical compounds characterized by their ability to selectively modulate the activity of the olfactory receptor 400 (Olr400), which belongs to the large family of G-protein-coupled receptors (GPCRs). Olr400 is involved in the detection and transduction of specific odorant molecules in the olfactory system, and its inhibition has significant implications for understanding olfactory signal processing. The inhibitors in this class typically exhibit a high degree of specificity, targeting the Olr400 receptor through distinct binding interactions that modulate its conformational states. These interactions can either prevent the receptor from binding to its natural ligands or disrupt the receptor's ability to activate downstream signaling pathways, effectively altering the perception of certain odors. The development and study of Olr400 inhibitors require a detailed understanding of the receptor's structure, particularly its ligand-binding domain, which is often a target for these inhibitors.
The chemical diversity among Olr400 inhibitors is notable, as various structural scaffolds can serve as the foundation for these molecules. Some inhibitors are small organic compounds with heterocyclic cores, while others may contain aromatic ring systems or fused ring structures that interact with the receptor's hydrophobic pockets. Additionally, the presence of functional groups such as amides, sulfonamides, or hydroxyl groups can enhance binding affinity and selectivity by forming hydrogen bonds or van der Waals interactions with the receptor's active site. Structure-activity relationship (SAR) studies are crucial in optimizing these inhibitors, enabling the fine-tuning of molecular features to achieve maximal inhibitory potency while maintaining selectivity. Research into Olr400 inhibitors contributes to a broader understanding of GPCR modulation, offering insights into the fundamental mechanisms of olfaction and receptor-ligand interactions at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
ACE inhibitor, can indirectly influence GPCR signaling associated with the renin-angiotensin system, impacting Olr400. | ||||||
Isradipine | 75695-93-1 | sc-201467 sc-201467A | 10 mg 50 mg | $88.00 $324.00 | 1 | |
Calcium channel blocker, could modulate GPCR signaling indirectly by altering calcium dynamics, impacting Olr400. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Angiotensin II receptor blocker, might modulate GPCR signaling indirectly, impacting Olr400. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
Calcium channel blocker, could alter GPCR signaling pathways through calcium modulation, potentially impacting Olr400. | ||||||
Ramipril | 87333-19-5 | sc-205833 sc-205833A sc-205833B sc-205833C sc-205833D | 500 mg 1 g 2 g 5 g 10 g | $179.00 $245.00 $364.00 $733.00 $1254.00 | 1 | |
ACE inhibitor, may indirectly affect GPCR signaling pathways related to the renin-angiotensin system, impacting Olr400. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Angiotensin II receptor blocker, can indirectly influence GPCR signaling, potentially impacting Olr400. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $40.00 $92.00 $122.00 | 4 | |
Angiotensin II receptor blocker, could indirectly affect GPCR signaling, potentially impacting Olr400. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker, may influence GPCR signaling indirectly through calcium ion dynamics, impacting Olr400. | ||||||